MAKE APPOINTMENT

Researchers Identify an Ancient Immune Protein That May Explain Why Some Tumors Resist Checkpoint Drugs

by | Aug 10, 2026 | Uncategorized | 0 comments

Complement C3 produced within tumors kept immunosuppressive cells out and improved checkpoint immunotherapy response in mice, researchers report.

Submit a Comment

Your email address will not be published. Required fields are marked *